- Home
- ONEG vs SGHT Comparison
ONEG vs SGHT Comparison
Compare ONEG & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- SGHT
- Stock Information
- Founded
- ONEG 2021
- SGHT 2011
- Country
- ONEG Hong Kong
- SGHT United States
- Employees
- ONEG 26
- SGHT N/A
- Industry
- ONEG Homebuilding
- SGHT Medical Specialities
- Sector
- ONEG Consumer Discretionary
- SGHT Health Care
- Exchange
- ONEG Nasdaq
- SGHT Nasdaq
- Market Cap
- ONEG 181.8M
- SGHT 193.2M
- IPO Year
- ONEG 2024
- SGHT 2021
- Fundamental
- Price
- ONEG $11.42
- SGHT $3.50
- Analyst Decision
- ONEG
- SGHT Buy
- Analyst Count
- ONEG 0
- SGHT 8
- Target Price
- ONEG N/A
- SGHT $4.29
- AVG Volume (30 Days)
- ONEG 260.4K
- SGHT 104.0K
- Earning Date
- ONEG 01-01-0001
- SGHT 11-06-2025
- Dividend Yield
- ONEG N/A
- SGHT N/A
- EPS Growth
- ONEG N/A
- SGHT N/A
- EPS
- ONEG 0.08
- SGHT N/A
- Revenue
- ONEG $53,205,000.00
- SGHT $76,303,000.00
- Revenue This Year
- ONEG N/A
- SGHT N/A
- Revenue Next Year
- ONEG N/A
- SGHT $12.04
- P/E Ratio
- ONEG $147.84
- SGHT N/A
- Revenue Growth
- ONEG N/A
- SGHT N/A
- 52 Week Low
- ONEG $1.48
- SGHT $2.03
- 52 Week High
- ONEG $13.50
- SGHT $6.82
- Technical
- Relative Strength Index (RSI)
- ONEG 52.74
- SGHT 43.67
- Support Level
- ONEG $10.08
- SGHT $3.39
- Resistance Level
- ONEG $11.82
- SGHT $3.74
- Average True Range (ATR)
- ONEG 0.86
- SGHT 0.16
- MACD
- ONEG -0.31
- SGHT -0.00
- Stochastic Oscillator
- ONEG 42.25
- SGHT 36.99
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.